Mayo Clin Proc Innov Qual Outcomes. 2017 Apr 28;1(1):37-48. doi: 10.1016/j.mayocpiqo.2017.04.004. eCollection 2017 Jul.
Acute Alcoholic Hepatitis: Natural History and Predictors of Mortality Using a Multicenter Prospective Study.
Mayo Clinic proceedings. Innovations, quality & outcomes
Spencer Lourens, Dharma B Sunjaya, Ashwani Singal, Suthat Liangpunsakul, Puneet Puri, Arun Sanyal, Xiaowei Ren, Gregory J Gores, Svetlana Radaeva, Naga Chalasani, David W Crabb, Barry Katz, Patrick S Kamath, Vijay H Shah,
Affiliations
Affiliations
- Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN.
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
- Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, AL.
- Roudebush Veterans Administration Medical Center, Indianapolis, IN.
- Division of Gastroenterology and Hepatology, Department of Medicine, Virginia Commonwealth University, Richmond.
- Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN.
- National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD.
- Eskenazi Health Hospital, Indianapolis, IN.
PMID: 30225400
PMCID: PMC6134907 DOI: 10.1016/j.mayocpiqo.2017.04.004
Abstract
OBJECTIVE: To examine the natural history of acute alcoholic hepatitis (AH) and identify predictors of mortality for AH using data from a prospective multicenter observational study.
PARTICIPANTS AND METHODS: We analyzed data from 164 patients with AH and 131 heavy-drinking controls with no liver disease. Participants underwent clinical/laboratory assessment at baseline and 6 and 12 months after enrollment. Multivariable analyses were conducted to identify variables associated with mortality and examine the association between coffee drinking and risk of AH.
RESULTS: Thirty-six patients with AH died during follow-up, with estimated 30-day, 90-day, 180-day, and 1-year survival of 0.91 (95% CI, 0.87-0.96), 0.85 (95% CI, 0.80-0.91), 0.80 (95% CI, 0.74-0.87), and 0.75 (95% CI, 0.68-0.83), respectively. In the multivariable analysis, higher serum bilirubin level (hazard ratio [HR]=1.059; 95% CI, 1.022-1.089), lower hemoglobin level (HR=1.263; 95% CI, 1.012-1.575), and lower platelet count (HR=1.006; 95% CI, 1.001-1.012) were independently associated with mortality in AH. Compared with controls, fewer patients with AH regularly consumed coffee (20% vs 44%;
CONCLUSION: Alcoholic hepatitis remains highly fatal, with 1-year mortality of 25%. Regular coffee consumption was associated with lower risk of AH in heavy drinkers.
Keywords: ABIC, age, serum bilirubin, international normalized ratio, and serum creatinine; AH, alcoholic hepatitis; AIC, Akaike Information Criterion; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUC, area under the curve; BMI, body mass index; CP, Child-Pugh; HR, hazard ratio; INR, international normalized ratio; IQR, interquartile range; MELD, Model for End-Stage Liver Disease; NA, not applicable; OR, odds ratio; ROC, receiver operating characteristic; STOPAH, Steroids or Pentoxifylline for Alcoholic Hepatitis; TREAT, Translational Research and Evolving Alcoholic Hepatitis Treatment; WBC, white blood cell; mDF, Maddrey Discriminant Function
References
- N Engl J Med. 2009 Jun 25;360(26):2758-69 - PubMed
- Gastroenterology. 2005 Dec;129(6):1928-36 - PubMed
- Gastroenterology. 2007 May;132(5):1740-5 - PubMed
- N Engl J Med. 2015 Apr 23;372(17):1619-28 - PubMed
- Gastroenterology. 2010 Sep;139(3):828-35, 835.e1-3 - PubMed
- Gut. 1997 Dec;41(6):845-50 - PubMed
- J Hepatol. 2005 May;42(5):700-6 - PubMed
- Hepatology. 2007 Jun;45(6):1348-54 - PubMed
- Hepatology. 1996 May;23(5):1025-9 - PubMed
- Clin Gastroenterol Hepatol. 2014 Apr;12(4):555-64; quiz e31-2 - PubMed
- J Appl Toxicol. 2013 Sep;33(9):970-9 - PubMed
- Gastroenterology. 2016 Apr;150(4):785-90 - PubMed
- Nat Genet. 2010 Jan;42(1):21-3 - PubMed
- Gastroenterology. 2005 Jan;128(1):24-32 - PubMed
- Alcohol Alcohol. 1998 Jul-Aug;33(4):381-92 - PubMed
- J Clin Gastroenterol. 2011 Sep;45(8):714-9 - PubMed
- J Alzheimers Dis. 2011;27(3):553-66 - PubMed
- J Gastroenterol Hepatol. 2014 Mar;29(3):435-41 - PubMed
- J Clin Gastroenterol. 2015 Jul;49(6):506-11 - PubMed
- Nat Genet. 2015 Dec;47(12):1443-8 - PubMed
- Hepatology. 2005 Feb;41(2):353-8 - PubMed
- Semin Liver Dis. 2004 Aug;24(3):217-32 - PubMed
- Clin Gastroenterol Hepatol. 2016 Dec;14(12):1831-1838.e3 - PubMed
- Biometrics. 2000 Jun;56(2):337-44 - PubMed
Publication Types
Grant support